Effectiveness of Neural Therapy in Patients With Fibromiyalgia

Sponsor
Hitit University (Other)
Overall Status
Completed
CT.gov ID
NCT04007172
Collaborator
(none)
60
1
2
3.7
16

Study Details

Study Description

Brief Summary

Neural therapy is a regulation therapy that tries to correct this underlying autonomic dysfunction. In neural therapy; local painful areas, trigger points and symptomatic segments are included in the injection using local anesthetics and the underlying disruptive areas are investigated and treated. The aim of this study was to investigate the efficacy of neural therapy in fibromyalgia syndrome which is thought to have a neuroendocrine dysregulation disorder.

Condition or Disease Intervention/Treatment Phase
  • Procedure: neural therapy
  • Device: Physical Therapy
N/A

Detailed Description

Fibromyalgia is a chronic disease characterized by widespread body pain, fatigue, sleep disturbance, and tenderness on palpation at trigger points in the musculoskeletal system.

Fibromyalgia prevalence is reported between 3% and 9%, and is three times more common in women than men. Although pharmacological and non-pharmacological approaches play a role in the treatment of the disease, the interest in non-pharmacological therapies has recently increased. In several studies, it has been shown that almost every fibromyalgia patient has applied at least one alternative and complementary medicine method such as Qigong, Tai Chi, yoga, mind body interventions, acupuncture, hydrotherapy, balneotherapy or phytotherapy.

Neural therapy is a regulation therapy that tries to correct this underlying autonomic dysfunction. In neural therapy; local painful areas, trigger points and symptomatic segments are included in the injection using local anesthetics and the underlying disruptive areas are investigated and treated. The aim of this study was to investigate the efficacy of neural therapy in fibromyalgia syndrome which is thought to have a neuroendocrine dysregulation disorder.

Study Design

Study Type:
Interventional
Actual Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Effectiveness of Neural Therapy in Patients With Fibromiyalgia
Actual Study Start Date :
Jan 20, 2019
Actual Primary Completion Date :
Apr 20, 2019
Actual Study Completion Date :
May 14, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Neural Therapy & home exercise program

Intracutaneous quaddle injections were performed using 1% lidocaine preparation as a local anesthetic for local application to painful points with palpation on the back and shoulders and for the segmental application, 2 cm lateral to the midline of the C1-T5 vertebrae and on spinous processes. Both the groups received education about fibromyalgia and home exercise program, which included stretching, strengthening, and aerobic exercises.

Procedure: neural therapy
Intracutaneous quaddle injections were performed using 1% lidocaine preparation as a local anesthetic for local application to painful points with palpation on the back and shoulders and for the segmental application, 2 cm lateral to the midline of the C1-T5 vertebrae and on spinous processes.

Experimental: Physical Therapy & home exercise program

Physical therapy program was consist of transcutaneous electrical nerve stimulation- TENS (30-40 Hz, 20 minutes), hotpack (20 minutes) and continuous ultrasound (1mHz, 1.5w / cm2, 10 minutes) on painful points with palpation on the back and shoulders. Both the groups received education about fibromyalgia and home exercise program, which included stretching, strengthening, and aerobic exercises.

Device: Physical Therapy
Physical therapy program was consist of transcutaneous electrical nerve stimulation- TENS (30-40 Hz, 20 minutes), hotpack (20 minutes) and continuous ultrasound (1mHz, 1.5w / cm2, 10 minutes) on painful points with palpation on the back and shoulders.

Outcome Measures

Primary Outcome Measures

  1. Visual analog scale for pain [4 weeks]

    Pain intensity was measured with visual analogue scale for pain (0-10 mm; 0 means no pain, 10 means severe pain) which is used to measure musculoskeletal pain with very good reliability and validity.

Secondary Outcome Measures

  1. Fibromyalgia Impact Questionnaire [4 weeks]

    The Fibromyalgia Impact Questionnaire was designed to measure the health status of patients with fibromyalgia that contains the dimensions physical functioning (11 items), well-being (1 item), work situation (2 items), pain (1 item), fatigue /sleep (2 items), stiffness (2 items) and psychological symptoms (2 items). Total score range from 0 to 100, with higher scores indicating higher levels of symptoms and severity.

  2. Short- form health survey 36 scores [4 weeks]

    Short- form health survey 36 contains 36 items which are used to evaluate the quality of life of patients with chronic pain. It measures eight different domains that address physical functioning, physical role limitation, pain, general health, vitality, social functioning, emotional role limitation and mental health. The score of each domain ranges from 0 (worse quality of life) to 100 (best quality of life).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Subjects diagnosed according to the American College of Rheumatology 2016 diagnostic criteria for fibromyalgia.
Exclusion Criteria:
  • History of comorbid inflammatory rheumatic/ connective tissue diseases

  • History of cardiovascular or musculoskeletal problems that could prevent them to participate in an exercise program

Contacts and Locations

Locations

Site City State Country Postal Code
1 Tuğba Atan Çorum Turkey 19100

Sponsors and Collaborators

  • Hitit University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Tuğba Atan, Assoc. Prof., Hitit University
ClinicalTrials.gov Identifier:
NCT04007172
Other Study ID Numbers:
  • 2019-114
First Posted:
Jul 5, 2019
Last Update Posted:
Jul 8, 2019
Last Verified:
Jul 1, 2019
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Tuğba Atan, Assoc. Prof., Hitit University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 8, 2019